Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Virtus LifeSci Biotech Products ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BBP.
Open | - |
High | - |
52 Wk High | $69.12 |
AUM | 23.22M |
Dividend | - |
Ex-Div Date | - |
Volume | - |
Market Cap | $13.05B |
Mgmt Fee | 0.79% |
P/E Ratio | 17.95 |
Prev. Close | $58.89 |
Low | - |
52 Wk Low | $48.65 |
Shares Out | 350.00K |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | 2.93K |
Beta | 0.65 |
Avg. Expense Ratio | 0.79% |
P/B Ratio | 3.87 |
You can purchase shares of Virtus LifeSci Biotech Products ETF (ARCA:BBP) through any online brokerage.
There are no as such competitors for Virtus LifeSci Biotech Products ETF.
There is no analysis for Virtus LifeSci Biotech Products ETF to provide a consensus price target.
The stock price for Virtus LifeSci Biotech Products ETF (ARCA: BBP) is $58.89 last updated April 30, 2025 at 8:00 PM EDT.
A quarterly cash dividend of 0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on December 27, 2017 to stockholders of record on December 20, 2017.
Virtus LifeSci Biotech Products ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Virtus LifeSci Biotech Products ETF.
Open | - |
High | - |
52 Wk High | $69.12 |
AUM | 23.22M |
Dividend | - |
Ex-Div Date | - |
Volume | - |
Market Cap | $13.05B |
Mgmt Fee | 0.79% |
P/E Ratio | 17.95 |
Prev. Close | $58.89 |
Low | - |
52 Wk Low | $48.65 |
Shares Out | 350.00K |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | 2.93K |
Beta | 0.65 |
Avg. Expense Ratio | 0.79% |
P/B Ratio | 3.87 |
Sector | Healthcare |
Category | Mid Performer-Mid Growth |
Investment Style | Mid Cap Growth |
Fund Inception | Dec 16, 2014 |
Managers | Seth Kadushin Paul Yook Andrew McDonald Matthew B. Brown |
Definition | Most of the stocks in this equity fund have average financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
ADMA | Adma Biologics Inc Com | 4.54% |
INSM | Insmed Inc | 3.66% |
TARS | Tarsus Pharmaceuticals... | 3.31% |
MRNA | Moderna therapeutics | 3.19% |
DCPH | Deciphera Pharmaceutic... | 3.10% |
AGIO | Agios Pharmaceuticals ... | 3.01% |
SRPT | Sarepta Therapeutics I... | 2.64% |
PTCT | Ptc Therapeutics Inc | 2.53% |
LXRX | Lexicon Pharmaceutcl | 2.51% |
BPMC | Blueprintmedicines Cor... | 2.42% |
ITCI | Intra-Cellular Therapi... | 2.56% |
BGNE | Beigene, Ltd. (adr) | 2.64% |
SH | Zai Lab Ltd-adr | 2.37% |
SAGE | Sage Therapeutics, Inc | 2.45% |
AXSM | Axsome Therapeutics, I... | 2.16% |
SWTX | Springworks Therapeuti... | 2.00% |
BBIO | Bridgebio Pharma Llc | 2.19% |
GILD | Gilead Sciences Inc | 2.14% |
HALO | Halozyme Therapeutics ... | 2.34% |
CO | Ascendis Pharma As Adr | 1.94% |
TGTX | Tg Therapeutics Inc Co... | 2.25% |
ASND | Ascendis Pharma A/S | 2.09% |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.